| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins
|
Pollock, YaoYao G.
|
|
2016
|
160 |
2 |
p. 291-296
|
artikel
|
| 2 |
Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis
|
Hervik, Jill Brook
|
|
2016
|
160 |
2 |
p. 223-236
|
artikel
|
| 3 |
A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
|
Reix, Nathalie
|
|
2016
|
160 |
2 |
p. 249-259
|
artikel
|
| 4 |
Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium
|
Beaber, Elisabeth F.
|
|
2016
|
160 |
2 |
p. 323-331
|
artikel
|
| 5 |
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
|
Tolaney, Sara M.
|
|
2016
|
160 |
2 |
p. 305-312
|
artikel
|
| 6 |
Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988–2013
|
Kurian, Allison W.
|
|
2016
|
160 |
2 |
p. 333-338
|
artikel
|
| 7 |
Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer
|
Leopold, Christine
|
|
2016
|
160 |
2 |
p. 385
|
artikel
|
| 8 |
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome
|
Tiainen, Satu
|
|
2016
|
160 |
2 |
p. 237-247
|
artikel
|
| 9 |
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer
|
Deutsch, Thomas M.
|
|
2016
|
160 |
2 |
p. 277-290
|
artikel
|
| 10 |
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)
|
Golshan, Mehra
|
|
2016
|
160 |
2 |
p. 297-304
|
artikel
|
| 11 |
Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients
|
Li, Zibo
|
|
2016
|
160 |
2 |
p. 371-383
|
artikel
|
| 12 |
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
|
Nordenskjöld, Anna
|
|
2016
|
160 |
2 |
p. 313-322
|
artikel
|
| 13 |
Prognostic models in male breast cancer
|
Pol, Carmen C. van der
|
|
2016
|
160 |
2 |
p. 339-346
|
artikel
|
| 14 |
Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis
|
Zheng, Qiufan
|
|
2016
|
160 |
2 |
p. 197-209
|
artikel
|
| 15 |
The 2016 Assisi Think Tank Meeting on breast cancer: white paper
|
Aristei, Cynthia
|
|
2016
|
160 |
2 |
p. 211-221
|
artikel
|
| 16 |
The association between China’s Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study
|
Alimujiang, Aliya
|
|
2016
|
160 |
2 |
p. 361-369
|
artikel
|
| 17 |
The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis
|
Hartman, Emily K.
|
|
2016
|
160 |
2 |
p. 347-360
|
artikel
|
| 18 |
Treatment with aromatase inhibitors and markers of cardiovascular disease
|
Blondeaux, Eva
|
|
2016
|
160 |
2 |
p. 261-267
|
artikel
|
| 19 |
Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience
|
Yang, Eun Joo
|
|
2016
|
160 |
2 |
p. 269-276
|
artikel
|
Tijdschrift beschrijving